HIV Core Protein p24

"HIV Core Protein p24" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A major core protein of the human immunodeficiency virus encoded by the HIV gag gene. HIV-seropositive individuals mount a significant immune response to p24 and thus detection of antibodies to p24 is one basis for determining HIV infection by ELISA and Western blot assays. The protein is also being investigated as a potential HIV immunogen in vaccines.

Descriptor ID	D016655
MeSH Number(s)	D12.776.964.775.350.362.500 D12.776.964.775.562.750.500 D12.776.964.970.600.850.350.362.500 D23.050.327.520.300
Concept/Terms	HIV Core Protein p24 HIV Core Protein p24 HIV gag Gene Product p24 HIV Major Core Protein p24 p24(HIV) HIV Protein p24 p24, HIV Protein HTLV-III p24 HTLV III p24 p24, HTLV-III p24 protein, Human Immunodeficiency Virus gag Protein p24, HIV HIV p24 Antigen p24 Antigen, HIV

Below are MeSH descriptors whose meaning is more general than "HIV Core Protein p24".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Viral Proteins [D12.776.964]
Retroviridae Proteins [D12.776.964.775]
Gene Products, gag [D12.776.964.775.350]
gag Gene Products, Human Immunodeficiency Virus [D12.776.964.775.350.362]
HIV Core Protein p24 [D12.776.964.775.350.362.500]
Human Immunodeficiency Virus Proteins [D12.776.964.775.562]
gag Gene Products, Human Immunodeficiency Virus [D12.776.964.775.562.750]
HIV Core Protein p24 [D12.776.964.775.562.750.500]
Viral Structural Proteins [D12.776.964.970]
Nucleocapsid Proteins [D12.776.964.970.600]
Viral Core Proteins [D12.776.964.970.600.850]
Gene Products, gag [D12.776.964.970.600.850.350]
gag Gene Products, Human Immunodeficiency Virus [D12.776.964.970.600.850.350.362]
HIV Core Protein p24 [D12.776.964.970.600.850.350.362.500]
Biological Factors [D23]
Antigens [D23.050]
Antigens, Viral [D23.050.327]
HIV Antigens [D23.050.327.520]
HIV Core Protein p24 [D23.050.327.520.300]

Below are MeSH descriptors whose meaning is related to "HIV Core Protein p24".

Below are MeSH descriptors whose meaning is more specific than "HIV Core Protein p24".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "HIV Core Protein p24" by people in this website by year, and whether "HIV Core Protein p24" was a major or minor topic of these publications.

Bar chart showing 9 publications over 7 distinct years, with a maximum of 2 publications in 2010 and 2018

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	1	1
2005	1	0	1
2007	0	1	1
2008	0	1	1
2010	1	1	2
2016	0	1	1
2018	0	2	2

Below are the most recent publications written about "HIV Core Protein p24" by people in Profiles.

L?pez OV, Gorantla S, Segarra AC, Andino Norat MC, ?lvarez M, Skolasky RL, Mel?ndez LM. Sigma-1 Receptor Antagonist (BD1047) Decreases Cathepsin B Secretion in HIV-Infected Macrophages Exposed to Cocaine. J Neuroimmune Pharmacol. 2019 06; 14(2):226-240.

View in: PubMed
Rosario-Rodr?guez LJ, Col?n K, Borges-V?lez G, Negr?n K, Mel?ndez LM. Dimethyl Fumarate Prevents HIV-Induced Lysosomal Dysfunction and Cathepsin B Release from Macrophages. J Neuroimmune Pharmacol. 2018 09; 13(3):345-354.

View in: PubMed
Martinez ZS, Castro E, Seong CS, Cer?n MR, Echegoyen L, Llano M. Fullerene Derivatives Strongly Inhibit HIV-1 Replication by Affecting Virus Maturation without Impairing Protease Activity. Antimicrob Agents Chemother. 2016 10; 60(10):5731-41.

View in: PubMed
Gu R, Shampang A, Nashar T, Patil M, Fuller DH, Ramsingh AI. Oral immunization with a live coxsackievirus/HIV recombinant induces gag p24-specific T cell responses. PLoS One. 2010 Sep 02; 5(9).

View in: PubMed
Schaubert KL, Price DA, Salkowitz JR, Sewell AK, Sidney J, Asher TE, Blondelle SE, Adams S, Marincola FM, Joseph A, Sette A, Douek DC, Ayyavoo V, Storkus W, Leung MY, Ng HL, Yang OO, Goldstein H, Wilson DB, Kan-Mitchell J. Generation of robust CD8+ T-cell responses against subdominant epitopes in conserved regions of HIV-1 by repertoire mining with mimotopes. Eur J Immunol. 2010 Jul; 40(7):1950-62.

View in: PubMed
Nair MP, Saiyed ZM, Nair N, Gandhi NH, Rodriguez JW, Boukli N, Provencio-Vasquez E, Malow RM, Miguez-Burbano MJ. Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells. J Neuroimmune Pharmacol. 2009 Mar; 4(1):129-39.

View in: PubMed
Aidoo M, Otten RA, Rodriguez V, Sariol CA, Martinez M, Kraiselburd E, Robinson H, Folks T, Butera S, Ellenberger D. Absence of SHIV infection in gut and lymph node tissues in rhesus monkeys after repeated rectal challenges following HIV-1 DNA/MVA immunizations. Vaccine. 2007 Aug 29; 25(35):6474-81.

View in: PubMed
Hao YL, Ma MQ, Fu JJ, Li HS, Wang YJ, Liu Y, Wu L, Liu Y, Shao YM. [Expression in Pichia pastoris, fermentation and purification of HIV-1 CN54 Gag antigen]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2005 Jun; 19(2):128-31.

View in: PubMed
Kazanjian P, Adams D, Tate S, Newman G. HIV production from purified monocytes isolated from antiretroviral-na?ve and protease inhibitor-treated HIV-1-infected patients. HIV Clin Trials. 2002 Nov-Dec; 3(6):469-74.

View in: PubMed
Dezzutti CS, Swords WE, Guenthner PC, Sasso DR, Wahl LM, Drummond AH, Newman GW, King CH, Quinn FD, Lal RB. Involvement of matrix metalloproteinases in human immunodeficiency virus type 1-induced replication by clinical Mycobacterium avium isolates. J Infect Dis. 1999 Oct; 180(4):1142-52.

View in: PubMed

People

Explore

Similar Concepts

Top Journals